![]() |
|
|

,2
Institute of Pharmacological Sciences, Faculty of Pharmacy and
*
Department of Agrifood Molecular Sciences, University of Milan, I-20133 Milan, Italy;
Centre for Human Nutrition, Department of Biochemistry, The University of Western Ontario, London, N6A 5C1 Canada
1To whom correspondence should be addressed.
The activation of LDL receptors was described recently in a human
hepatoma cell line (Hep G2) exposed both to
+
' subunits from 7S
soy globulin and to CroksoyR70, a commercial
isoflavone-poor soy concentrate. To assess the final identity of
the peptide(s) putatively responsible for the biochemical effect,
experiments were performed in Hep G2 cells, exposed either to synthetic
peptides corresponding to specific sequences of 7S soy globulin or to
peptides from the in vitro digestion of CroksoyR70.
Moreover, the ability of the whole 7S globulin, its subunits and whole
CroksoyR70 to interfere in the apolipoprotein B (apo B)
secretion in the medium as well as in sterol biosynthesis was evaluated
in the same model. Increased 125I-LDL uptake and
degradation vs. controls were shown after Hep G2 incubation with a
synthetic peptide (10-4 mol/L, MW 2271 Da)
corresponding to positions 127150 of the 7S globulin. Cells exposed
to CroksoyR70 enzyme digestion products showed a more
marked up-regulation of LDL receptors vs. controls, compared with
vs. Hep G2 cells incubated with undigested CroksoyR70.
Among soy-derived products, only the 7S globulin inhibited apo B
secretion and 14C-acetate incorporation when tested in Hep
G2 cells at a concentration of 1.0 g/L. These findings support the
hypothesis that if one or more peptides can reach the liver after
intestinal digestion, they may elicit a cholesterol-lowering
effect. Moreover, the protein moiety, devoid of isoflavone components,
is likely to be responsible for this major biochemical effect of soy
protein.
KEY WORDS: soy proteins LDL receptors apolipoprotein B cholesterol homeostasis Hep G2 cells
This article has been cited by other articles:
![]() |
S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression J. Nutr., February 1, 2008; 138(2): 332 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R Matthan, S. M Jalbert, L. M Ausman, J. T Kuvin, R. H Karas, and A. H Lichtenstein Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects Am. J. Clinical Nutrition, April 1, 2007; 85(4): 960 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Klopotek, F. Hirche, and K. Eder PPAR{gamma} Ligand Troglitazone Lowers Cholesterol Synthesis in HepG2 and Caco-2 Cells via a Reduced Concentration of Nuclear SREBP-2 Experimental Biology and Medicine, September 1, 2006; 231(8): 1365 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dewell, P. L. W. Hollenbeck, and C. B. Hollenbeck A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 772 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ma, D. Chiriboga, B. C. Olendzki, R. Nicolosi, P. A. Merriam, and I. S. Ockene Effect of Soy Protein Containing Isoflavones on Blood Lipids in Moderately Hypercholesterolemic Adults: A Randomized Controlled Trial J. Am. Coll. Nutr., August 1, 2005; 24(4): 275 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhan and S. C Ho Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile Am. J. Clinical Nutrition, February 1, 2005; 81(2): 397 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Greany, J. A. Nettleton, K. E. Wangen, W. Thomas, and M. S. Kurzer Probiotic Consumption Does Not Enhance the Cholesterol-Lowering Effect of Soy in Postmenopausal Women J. Nutr., December 1, 2004; 134(12): 3277 - 3283. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mullen, R. M. Brown, T. F. Osborne, and N. F. Shay Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells J. Nutr., November 1, 2004; 134(11): 2942 - 2947. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Duranti, M. R. Lovati, V. Dani, A. Barbiroli, A. Scarafoni, S. Castiglioni, C. Ponzone, and P. Morazzoni The {alpha}' Subunit from Soybean 7S Globulin Lowers Plasma Lipids and Upregulates Liver {beta}-VLDL Receptors in Rats Fed a Hypercholesterolemic Diet J. Nutr., June 1, 2004; 134(6): 1334 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Xiao, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and S. A. Papademetriou Dietary Soy Protein Isolate and Isoflavones Modulate Hepatic Thyroid Hormone Receptors in Rats J. Nutr., April 1, 2004; 134(4): 743 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Adams, D. L. Golden, A. A. Franke, S. M. Potter, H. S. Smith, and M. S. Anthony Dietary Soy {beta}-Conglycinin (7S Globulin) Inhibits Atherosclerosis in Mice J. Nutr., March 1, 2004; 134(3): 511 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Sirtori, M. R. Lovati, C. Manzoni, S. Castiglioni, M. Duranti, C. Magni, S. Morandi, A. D'Agostina, and A. Arnoldi Proteins of White Lupin Seed, a Naturally Isoflavone-Poor Legume, Reduce Cholesterolemia in Rats and Increase LDL Receptor Activity in HepG2 Cells J. Nutr., January 1, 2004; 134(1): 18 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Anderson Diet First, Then Medication for Hypercholesterolemia JAMA, July 23, 2003; 290(4): 531 - 533. [Full Text] [PDF] |
||||
![]() |
C. Manzoni, M. Duranti, I. Eberini, H. Scharnag, W. Marz, S. Castiglioni, and M. R. Lovati Subcellular Localization of Soybean 7S Globulin in HepG2 Cells and LDL Receptor Up-Regulation by Its {alpha}' Constituent Subunit J. Nutr., July 1, 2003; 133(7): 2149 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gianazza, I. Eberini, A. Arnoldi, R. Wait, and C. R. Sirtori A Proteomic Investigation of Isolated Soy Proteins with Variable Effects in Experimental and Clinical Studies J. Nutr., January 1, 2003; 133(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A.J.M. Kerckhoffs, F. Brouns, G. Hornstra, and R. P. Mensink Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols J. Nutr., September 1, 2002; 132(9): 2494 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Jenkins, C. W. Kendall, C.-J. C Jackson, P. W Connelly, T. Parker, D. Faulkner, E. Vidgen, S. C Cunnane, L. A Leiter, and R. G Josse Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women Am. J. Clinical Nutrition, August 1, 2002; 76(2): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Jenkins, C. W. Kendall, E. Vidgen, L. S. Augustin, M. van Erk, A. Geelen, T. Parker, D. Faulkner, V. Vuksan, R. G Josse, et al. High-protein diets in hyperlipidemia: effect of wheat gluten on serum lipids, uric acid, and renal function Am. J. Clinical Nutrition, July 1, 2001; 74(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||